Clinical Trials
4 trialsNCT06598306 2026-05-29
DeLLphi-308
Amgen
Phase 1 Recruiting
NCT07037758 2026-05-29
DeLLphi-311
Amgen
Phase 1 Recruiting
NCT05361395 2026-03-03
First-Line Tarlatamab in Combination With Carboplatin, Etoposide, and PD-L1 Inhibitor in Subjects With Extensive Stage Small Cell Lung Cancer (ES-SCLC)
Amgen
Phase 1 Active not recruiting
NCT04885998 2025-09-29
AMG 757 and AMG 404 in Subjects With Small Cell Lung Cancer (SCLC)
Amgen
Phase 1 Completed